Last reviewed · How we verify
0.25% bupivacaine with 1:200,000 epinephrine
0.25% bupivacaine with 1:200,000 epinephrine is a Small molecule drug developed by Jessyka Lighthall. It is currently in Phase 3 development.
At a glance
| Generic name | 0.25% bupivacaine with 1:200,000 epinephrine |
|---|---|
| Sponsor | Jessyka Lighthall |
| Modality | Small molecule |
| Phase | Phase 3 |
Approved indications
Common side effects
Key clinical trials
- Comparing Pain Relief Between Two Methods of Freezing Injections in Children Having Their Appendix Removed (NA)
- Laparoscopically Guided Rectus Sheath Block in Pediatric Appendicitis (PHASE2)
- Rhomboid Intercostal and Sub-Serratus Block for Improving Pulmonary Function and Pain in Patients With Fracture Ribs (NA)
- Transversus Abdominis Plane Block in Children Undergoing Ostomy Surgery (NA)
- Transversus Abdominis Plane Block in Children Undergoing Open Pyeloplasty Surgery (NA)
- A Comparison of Bupivacaine and Ketorolac for Postoperative Analgesia After Iliac Crest Bone Harvesting (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- 0.25% bupivacaine with 1:200,000 epinephrine CI brief — competitive landscape report
- 0.25% bupivacaine with 1:200,000 epinephrine updates RSS · CI watch RSS
- Jessyka Lighthall portfolio CI
Frequently asked questions about 0.25% bupivacaine with 1:200,000 epinephrine
What is 0.25% bupivacaine with 1:200,000 epinephrine?
0.25% bupivacaine with 1:200,000 epinephrine is a Small molecule drug developed by Jessyka Lighthall.
Who makes 0.25% bupivacaine with 1:200,000 epinephrine?
0.25% bupivacaine with 1:200,000 epinephrine is developed by Jessyka Lighthall (see full Jessyka Lighthall pipeline at /company/jessyka-lighthall).
What development phase is 0.25% bupivacaine with 1:200,000 epinephrine in?
0.25% bupivacaine with 1:200,000 epinephrine is in Phase 3.
Related
- Manufacturer: Jessyka Lighthall — full pipeline